Has plasma therapy failed in Covid-19 or we have failed in using it properly in India?–Lessons learned through the pandemic

India has literally been devastated by the second wave of the Covid-19. Convalescent plasma (CP) therapy which was approved initially for Covid-19 in India has been recently excluded from the Covid-19 management protocol. Herein we would like to explore the major challenges for CP therapy in India t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sankha Datta, S., Chakrabarty, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Société française de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. 2022
Materias:
Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359642/
https://www.ncbi.nlm.nih.gov/pubmed/34391927
http://dx.doi.org/10.1016/j.tracli.2021.08.002
_version_ 1783737590445244416
author Sankha Datta, S.
Chakrabarty, R.
author_facet Sankha Datta, S.
Chakrabarty, R.
author_sort Sankha Datta, S.
collection PubMed
description India has literally been devastated by the second wave of the Covid-19. Convalescent plasma (CP) therapy which was approved initially for Covid-19 in India has been recently excluded from the Covid-19 management protocol. Herein we would like to explore the major challenges for CP therapy in India that we observed during the current pandemic.
format Online
Article
Text
id pubmed-8359642
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Société française de transfusion sanguine (SFTS). Published by Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-83596422021-08-12 Has plasma therapy failed in Covid-19 or we have failed in using it properly in India?–Lessons learned through the pandemic Sankha Datta, S. Chakrabarty, R. Transfus Clin Biol Perspectives India has literally been devastated by the second wave of the Covid-19. Convalescent plasma (CP) therapy which was approved initially for Covid-19 in India has been recently excluded from the Covid-19 management protocol. Herein we would like to explore the major challenges for CP therapy in India that we observed during the current pandemic. Société française de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. 2022-02 2021-08-12 /pmc/articles/PMC8359642/ /pubmed/34391927 http://dx.doi.org/10.1016/j.tracli.2021.08.002 Text en © 2021 Société française de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Perspectives
Sankha Datta, S.
Chakrabarty, R.
Has plasma therapy failed in Covid-19 or we have failed in using it properly in India?–Lessons learned through the pandemic
title Has plasma therapy failed in Covid-19 or we have failed in using it properly in India?–Lessons learned through the pandemic
title_full Has plasma therapy failed in Covid-19 or we have failed in using it properly in India?–Lessons learned through the pandemic
title_fullStr Has plasma therapy failed in Covid-19 or we have failed in using it properly in India?–Lessons learned through the pandemic
title_full_unstemmed Has plasma therapy failed in Covid-19 or we have failed in using it properly in India?–Lessons learned through the pandemic
title_short Has plasma therapy failed in Covid-19 or we have failed in using it properly in India?–Lessons learned through the pandemic
title_sort has plasma therapy failed in covid-19 or we have failed in using it properly in india?–lessons learned through the pandemic
topic Perspectives
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359642/
https://www.ncbi.nlm.nih.gov/pubmed/34391927
http://dx.doi.org/10.1016/j.tracli.2021.08.002
work_keys_str_mv AT sankhadattas hasplasmatherapyfailedincovid19orwehavefailedinusingitproperlyinindialessonslearnedthroughthepandemic
AT chakrabartyr hasplasmatherapyfailedincovid19orwehavefailedinusingitproperlyinindialessonslearnedthroughthepandemic

Ejemplares similares